News Sentiment

BDSX sentiment intelligence

Biodesix Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 61 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 21.42 Week of 10 Jul 2026
Weighted tone 61/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

72/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-2.6% over one week, +42.2% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 72/100 classification
One-week reaction -2.6% Price reacting lower
Trend fit Trend active 42.2% over four weeks
Fair value 0.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 22
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
TradingView 5
TradingKey 5
Market source 5
timothysykes.com 2
www.marketscreener.com 2
MarketBeat 1
Simply Wall St. 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 15
Analyst action 6
Guidance 4
Balance sheet 2
Macro sensitivity 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45
Insider Monkey Direct company coverage

Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions

Canaccord has increased its price target for Biodesix (BDSX) from $20 to $22, maintaining a Buy rating, due to higher revenue assumptions and improved operating margins in its 10-year DCF model. This adjustment follows Biodesix's strong Q1 2026 results, which showed Diagnostic Te

Tone
Positive 85/100
Event
Earnings
Published
23 May 2026 12:38
Source
Insider Monkey
ChartMill Direct company coverage

BDSX News | BIODESIX INC (NASDAQ:BDSX)

This article provides a compilation of recent news and analysis related to Biodesix Inc (NASDAQ:BDSX). It includes past earnings reports, analyst expectations for stock rallies, and various other stock-related news where BDSX is mentioned alongside other companies. The current st

Tone
Positive 69/100
Event
Earnings
Published
23 May 2026 05:40
Source
ChartMill
Stock Titan Direct company coverage

Biodesix (NASDAQ: BDSX) registers 375,000 shares for Perceptive resale

Biodesix (NASDAQ: BDSX) has filed an S-3 registration statement to allow Perceptive Credit Holdings IV, LP to resell up to 375,000 shares of common stock. These shares are issuable upon the exercise of warrants granted under multiple amendments to a credit agreement. Biodesix wil

Tone
Neutral 50/100
Event
Balance sheet
Published
22 May 2026 03:33
Source
Stock Titan
Caledonian Record Direct company coverage

Biodesix to Participate in Upcoming Investor Conferences

Biodesix, Inc. announced its leadership team will participate in three investor conferences: Craig-Hallum 23rd Annual Institutional Investor Conference, William Blair 46th Annual Growth Stock Conference, and TD Cowen Annual Tools & Diagnostics Revolution Conference. The presentat

Tone
Positive 64/100
Event
Market update
Published
21 May 2026 09:39
Source
Caledonian Record